active
ACTIVE SINCE: 2021
Back to Collaborations

Bristol Myers Squibb Foundation: Propulmão Mobile Project

This project will offer low-dose computer tomography to high-risk populations for lung cancer to improve access to lung cancer diagnosis and prevention in the Northeast region of Brazil.
SGDS CONTRIBUTING TO:
MEMBER COMPANIES:
PARTNERING WITH:
SEE ALL PARTNER ORGANIZATIONS
Local NGOs 1
Pharma Company Foundation 1

This project will offer low-dose computer tomography to high-risk populations for lung cancer to improve access to lung cancer diagnosis and prevention in the Northeast region of Brazil. The Prompulmão Mobile Project aims to deliver coordinated care for best practices on lung cancer screening, diagnosis, and disease management for the Brazilian public and will leverage learnings of other successful global lung cancer programs and adapt them in Latin America.

Results and milestones
  • Capacity development in Primary Healthcare professional: tranining workshops conducted with 45 HCPs trained to date
  • Development of New Rapid Diagnostic Pathway: 2 Red Flag Protocols and decision tree developed for lung cancer and melanoma. 1 app in development for use in basic health units connecting HCPs to specialists, for identification and flagging of priority patients.
  • Patient navigation programs developed for lung cancer and melanoma
Geographic Reach
  • Americas
See Where
Disease Area
  • Non-communicable Diseases
See Disease Areas
SGDs the partnership contributes to
SDG 3: Good Health and Wellbeing
  1. 3.4: NCDs (including mental health)
  2. 3.8: Achieve universal health coverage
SDG 17: Partnerships for the Goals 
Partner organizations
Local NGOs

Senai Cimatec, SDS Healthline

Pharma Company Foundation

Bristol Myers Squibb Foundation

Geographic Reach

Americas

  • Brazil

Disease Area

Non-communicable Diseases

  • Cancer
    • Lung Cancer
    • Melanoma